December 14, 2021 | By John Raslavsky | Clinical Research, PCOS | Blog, Hepatic Clinical Trials, liver health, NAFLD, NASH
The prevalence of non-alcoholic fatty liver disease (NAFLD), a condition that encompasses excess fat accumulation, inflammation, and liver scarring, is on the rise. Multiple factors go into developing NAFLD, and it has been linked to several other conditions. Polycystic ovary …
November 29, 2021 | By John Raslavsky | Clinical Research, NAFLD | Blog, Clinical trials, Fatty Liver Disease, liver health
In the medical world, we are always trying to find new ways to treat all kinds of conditions. Non-alcoholic fatty liver disease, or NAFLD, is a condition that we are constantly learning more about, especially in the work of clinical …
October 27, 2021 | By John Raslavsky | Fibroscan, Hepatic Encephalopathy | Blog, Clinical research, Clinical trials, HE
Hepatic encephalopathy (HE) can develop when your liver can no longer remove toxic substances from your blood. The toxins build up and can travel through your body until they eventually reach your brain. This causes mental and physical symptoms of …
October 14, 2021 | By John Raslavsky | Clinical Trials, Fibroscan, Liver Awareness Month | Blog, NAFLD, NASH
The liver is one of the most vital organs in our bodies. It is impossible to survive without the life-sustaining functions it provides. Understandably, how well we take care of our liver impacts its ability to function properly. National Liver …
September 29, 2021 | By John Raslavsky | Cirrhosis, Fibroscan | Blog, Clinical trials, NAFLD, NASH
Cirrhosis of the liver is a progressive disease, developing slowly over many years. If allowed to continue, the buildup of scar tissue can eventually stop liver function. Because of the gradual decline, liver cirrhosis often goes undetected and unnoticed. You …
August 26, 2021 | By John Raslavsky | Cirrhosis, Clinical Trials, Liver Disease | Blog, NAFLD, NASH
Cirrhosis is when the permanent scarring of the liver has replaced the healthy tissue. While cirrhosis is most often associated with chronic alcohol consumption, it is brought about by many types of liver disease. Here’s how you get from liver disease …
August 4, 2021 | By John Raslavsky | Clinical Trials, Liver Disease | Blog, Caregiving, Clinical research, NAFLD, NASH
Having liver disease affects the person with it but also loved ones around them. Often a family member or friend fills the role of meeting a variety of physical and emotional needs. If you are a caregiver for someone with …
July 13, 2021 | By John Raslavsky | Clinical Trials, Liver Disease | Blog, Clinical trials, NAFLD, NASH
The number of U.S. adults with non-alcoholic fatty liver disease (NAFLD) currently sits around 25%. Approximately 2-3% of them will go on to develop non-alcoholic steatohepatitis (NASH). NASH is a more severe form of NAFLD and can lead to fibrosis, …
June 8, 2021 | By John Raslavsky | Clinical Trials, Fibroscan, Liver | Blog, Clinical research, liver disease research
When it comes to detecting and identifying the severity of liver disease, the gold standard is typically a liver biopsy. Newer technological advances have paved the way for other non-invasive options such as the fibroscan. Not only does it …
May 31, 2021 | By John Raslavsky | Clinical Trials, Liver | Blog, Liver research
Regular physical activity is the cornerstone of a healthier body and quality of life. It also has been proven to reduce your risk of chronic conditions like type 2 diabetes, heart disease, and dementia. Physical activity and liver disease …